Cellulose Triacetate Dialyzer Reduces Platelet Loss during Continuous Veno-Venous Hemofiltration

Thrombocytopenia is a common complication in patients receiving continuous veno-venous hemofiltration (CVVH) in the intensive care unit. The hemofilter itself plays an important role in the genesis of thrombocytopenia. The present study was undertaken to test whether there were differences in platelet loss and activation during CVVH with a polysulfone (PS) hemofilter or a cellulose triacetate (CTA) dialyzer. 96 patients with thrombocytopenia and acute kidney injury requiring CVVH were randomly assigned to four groups receiving low-molecular-weight heparin (LMWH) PS (n = 24), LMWH CTA (n = 24), no anticoagulation PS (n = 24), and no anticoagulation CTA (n = 24), respectively. We found a significant decrease in platelet counts, but an increased platelet activation with the PS hemofilter in patients who received no anticoagulation. There was no significant decrease in platelet counts and activation in the CTA group. The cellulose membranes could be an effective alternative to the standard synthetic membranes in patients at high risk for thrombocytopenia during CVVH.

[1]  J. Gibbins,et al.  Platelets and Megakaryocytes , 2004, Methods in Molecular Biology.

[2]  P. Bartels,et al.  The Role of the Extracorporeal Circuit in the Trapping and Degranulation of Platelets , 2009, Blood Purification.

[3]  G. Tangelder,et al.  Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility? , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  M. Böhm,et al.  Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study , 2008, Critical care.

[5]  C. Stehouwer,et al.  Platelet Activation during Haemodialysis: Comparison of Cuprammonium Rayon and Polysulfone Membranes , 2007, Blood Purification.

[6]  S. Eiam‐Ong,et al.  Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[7]  H. Nakamoto,et al.  Frequency of Anti-Heparin-PF4 Complex Antibodies (HIT Antibodies) in Uremic Patients on Chronic Intermittent Hemodialysis , 2006, Pathophysiology of Haemostasis and Thrombosis.

[8]  J. Fortenberry,et al.  Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  R. Bellomo,et al.  Continuous Venovenous Hemofiltration Without Anticoagulation , 2004, ASAIO journal.

[10]  R. Bellomo,et al.  Platelet Loss across the Hemofilter during Continuous Hemofiltration , 2003, The International journal of artificial organs.

[11]  K. Kanmatsuse,et al.  Comparison of the Effects of Cellulose Triacetate and Polysulfone Membrane on GPIIb/IIIa and Platelet Activation , 2003, Blood Purification.

[12]  E. Ballone,et al.  Cell Activation and Cellular-Cellular Interactions during Hemodialysis: Effect of Dialyzer Membrane , 2002, The International journal of artificial organs.

[13]  M. Singer,et al.  Keeping the Circuit Open: Lessons from the Lab , 2002, Blood Purification.

[14]  A. Pascalis,et al.  Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  M. Schetz.  Anticoagulation for continuous renal replacement therapy , 2001, Current opinion in anaesthesiology.

[16]  C. Durbin,et al.  Oxford Textbook of Critical Care , 2000 .

[17]  A. Albertazzi,et al.  Leukocyte Adhesion Molecules and Leukocyte-Platelet Interactions during Hemodialysis: Effects of Different Synthetic Membranes , 1999, The International journal of artificial organs.

[18]  R. Bellomo,et al.  Cellulose triacetate: another membrane for continuous renal replacement therapy. , 1999, Journal of nephrology.

[19]  A. Cheung,et al.  Fibrinogen fragments and platelet dysfunction in uremia. , 1999, Kidney international.

[20]  C. Stoutenbeek,et al.  Cytokine Filtration and Adsorption during Pre- and Postdilution Hemofiltration in Four Different Membranes , 1998, Blood Purification.

[21]  L. Vitacolonna,et al.  Arteriovenous Fistula Obstruction and Expression of Platelet Receptors for Von Willebrand Factor and for Fibrinogen (Glycoproteins GPIb and GPIIb/llla) in Hemodialysis Patients , 1996, The International journal of artificial organs.

[22]  R. Westendorp,et al.  Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. , 1996, Journal of the American Society of Nephrology : JASN.

[23]  J. Radovich.  Composition of polymer membranes for therapies of end-stage renal disease. , 1995, Contributions to nephrology.

[24]  G. Hempelmann,et al.  Platelet function in critically ill patients. , 1994, Chest.

[25]  G. Hempelmann,et al.  Continuous hemofiltration and platelet function in critically ill patients , 1994, Critical care medicine.

[26]  A. Remuzzi,et al.  Albumin Treatment Reduces in Vitro Platelet Deposition to Pmma Dialysis Membrane , 1993, The International journal of artificial organs.

[27]  A. Remuzzi,et al.  In vitro platelet adhesion to dialysis membranes. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  F. Turci,et al.  Hemodialysis-Associated Platelet Loss: Study of the Relative Contribution of Dialyzer Membrane Composition and Geometry , 1984, The International journal of artificial organs.